(Q48956742)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Kelly L Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Amanda Tristram

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kathleen M Gallagher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alison N Fiander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

27 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

published in

International Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

167-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623547%20AND%20SRC:MED&resulttype=core&format=json

Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer

6 January 2020

cites work

1 reference

12 December 2020

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

12 December 2020

HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs

1 reference

12 December 2020

A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

1 reference

12 December 2020

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses

1 reference

12 December 2020

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

1 reference

12 December 2020

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

12 December 2020

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

1 reference

12 December 2020

Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein

1 reference

12 December 2020

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

1 reference

12 December 2020

Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.

1 reference

12 December 2020

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins

1 reference

12 December 2020

Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter

1 reference

12 December 2020

Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types

1 reference

12 December 2020

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

12 December 2020

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

1 reference

12 December 2020

Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination

1 reference

12 December 2020

Cancer of the Uterine Cervix

1 reference

12 December 2020

Multiple mechanisms underlie HLA dysregulation in cervical cancer

1 reference

12 December 2020

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

12 December 2020

Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides

1 reference

12 December 2020

Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing

1 reference

12 December 2020

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

1 reference

12 December 2020

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens

1 reference

12 December 2020

Prevention of cervical cancer through papillomavirus vaccination

1 reference

12 December 2020

Immune evasion in human papillomavirus-associated cervical cancer

1 reference

12 December 2020

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

12 December 2020

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

1 reference

12 December 2020

Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes

1 reference

12 December 2020

High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease

1 reference

12 December 2020

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

12 December 2020

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

12 December 2020

T-helper epitopes of the E7 transforming protein of cervical cancer associated human papillomavirus type 18 (HPV18)

1 reference

12 December 2020

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

1 reference

12 December 2020

Replication of human papillomaviruses in cell culture

1 reference

12 December 2020

Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.

1 reference

12 December 2020

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

12 December 2020

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia

1 reference

12 December 2020

Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16

1 reference

12 December 2020

Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia

1 reference

12 December 2020

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376

1 reference

12 December 2020

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

12 December 2020

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

12 December 2020

Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection

1 reference

12 December 2020

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals

1 reference

12 December 2020

Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences

1 reference

12 December 2020

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

1 reference

12 December 2020

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

12 December 2020

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia

1 reference

12 December 2020